OMIC SINGULAR GENOMICS SYSTEMS INC

Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference

Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference

SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced plans to present at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, Florida.

Singular Genomics’ management is scheduled to participate in a fireside chat Wednesday, June 12, 2024, at 7:40 a.m. Pacific Time / 10:40 a.m. Eastern Time. Investors and other interested parties are invited to listen to a live and recorded webcast of the presentation at in the Presentations & Events section.

About Singular Genomics Systems, Inc.

Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4® Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In addition, the company is currently developing the G4X™ Spatial Sequencer, which will leverage Singular’s proprietary sequencing technology, applying it as an in situ readout for transcriptomics, proteomics and fluorescent H&E in tissue, with spatial context and on the same platform as the G4. Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine. Visit for more information.

Investor Contact

Philip Trip Taylor

Gilmartin Group

  

Media Contact

Matt Browning



EN
29/05/2024

Underlying

OMICSINGULAR GENOMICS SYSTEMS INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SINGULAR GENOMICS SYSTEMS INC

 PRESS RELEASE
Free
OMIC SINGULAR GENOMI...

Singular Highlights Key G4X™ Launch Milestones and Showcases Groundbre...

Singular Highlights Key G4X™ Launch Milestones and Showcases Groundbreaking 3D Spatial Multiomic Performance at AGBT SAN DIEGO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc., an innovator in high-throughput spatial multiomics technologies designed to advance precision medicine, today announced key development milestones for its G4X™ Spatial Sequencer at the Advances in Genome Biology and Technology (AGBT) conference in Marco Island, Florida. G4X Early Access Program Ongoing and Broader Availability on Track The G4X Early Access Program is currently underway a...

February 24, 2025 1 EN
 PRESS RELEASE
Free
OMIC SINGULAR GENOMI...

Singular Genomics Announces Closing of Acquisition by Deerfield Manage...

Singular Genomics Announces Closing of Acquisition by Deerfield Management SAN DIEGO, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today the closing of its acquisition by an affiliate of Deerfield Management Company, L.P.    On December 23, 2024, Singular Genomics announced that Deerfield had signed a definitive agreement to acquire all of the outstanding shares of Singular Genomics common stock not currently...

February 21, 2025 1 EN
 PRESS RELEASE
Free
OMIC SINGULAR GENOMI...

Singular Genomics Enters into Agreement to be Acquired by Deerfield fo...

Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC) (“Singular Genomics” or the “Company”), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it has entered into a definitive merger agreement whereby an affiliate of Deerfield Management Company, L.P. will acquire Singular Genomics in an all-cash transaction for $20.00 per share. The $20.00 per share...

December 23, 2024 1 EN
 PRESS RELEASE
Free
OMIC SINGULAR GENOMI...

Singular Genomics Reports Recent Updates and Third Quarter 2024 Financ...

Singular Genomics Reports Recent Updates and Third Quarter 2024 Financial Results SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the third quarter ended September 30, 2024. “In the third quarter, we made significant progress in the development of the G4X spatial sequencer,” said Drew Spaventa, Chairman and Chief Executive Office...

November 12, 2024 1 EN
 PRESS RELEASE
Free
OMIC SINGULAR GENOMI...

Singular Genomics Receives Non-Binding Acquisition Proposal from Conce...

Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today that it has received an unsolicited non-binding proposal from Concentra Biosciences, LLC (“Concentra”) to acquire all of the Company’s outstanding shares of common stock for $12.00 per share in cash. As alternative consideration, Concentra stated...

September 19, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch